Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

MapLight Therapeutics, Inc. (MPLT) Balance Sheet

As of 2026-06-30 (10-Q), MapLight Therapeutics, Inc. (MPLT) reported total assets of $368.3M, total liabilities of $20.0M and shareholders' equity of $348.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $71.6M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MPLTMapLight Therapeutics, Inc.Follow MPLT — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
369.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
1 Dec, in 38 days
LineFY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents46.771.6
Short-term investments258.4233.1
Current assets324.7318.8
Total assets479.5368.3
Current liabilities16.219.3
Total liabilities21.120.0
Shareholders' equity458.4348.3

USD millions · SEC XBRL

MapLight Therapeutics, Inc. — questions

How much cash does MapLight Therapeutics, Inc. have?
$71.6M in cash and cash equivalents as of 2026-06-30.
What are MapLight Therapeutics, Inc.'s total assets?
$368.3M as of 2026-06-30.
What is MapLight Therapeutics, Inc.'s shareholders' equity?
$348.3M as of 2026-06-30.

Every figure on this page comes from MapLight Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.